OPMD and HBV seems clearly where all the focus and strength lies now
Surprisingly, both have shown impressive pre-clinical success, due to HBV patents improvements made over many years 2015'16 and 18
OPMD due to its new "silence and replace technology and the teams vast experience.
Both of course with unmet treatments available
- Forums
- ASX - By Stock
- BLT
- Benitec trading volume
Benitec trading volume, page-87
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online